Navigation Links
Surveyed U.S. and European Neurologists Agree that a Therapy's Effect on Physical Disability is the Most Important Attribute Influencing Prescribing Decisions in Secondary-Progressive Multiple Sclerosis
Date:3/20/2013

BURLINGTON, Mass., March 20, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that a therapy's effect on physical disability is the most influential attribute when making prescribing decisions for secondary-progressive multiple sclerosis (SP-MS)*. These same neurologists cite a therapy's effect on quality of life as the second-most important attribute, ahead of an effect on relapses, imaging metrics and other functional domains.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO)

Current management of SP-MS relies on the use of mainline disease-modifying therapies (which include interferon-betas and Teva's Copaxone), most of which are approved broadly for the treatment of relapsing forms of MS. This category encompasses relapsing-remitting MS (RR-MS) and SP-MS patients who continue to experience relapses. Interviewed thought leaders suggest that, based on data in RR-MS, Genzyme/Sanofi/Bayer HealthCare's Lemtrada may offer advantages over sales-leading Copaxone on measures of physical disability—potentially translating into clinical benefits for SP-MS patients. 

"The neurologists we surveyed indicate that an improved effect on physical disability is one of the greatest unmet needs in SP-MS," said Decision Resources Analyst Georgiana L. Kuhlmann , S.M. "Drawing on clinical data from RR-MS trials, interviewed thought leaders indicate that Lemtrada has demonstrated the potential to partially fulfill this unmet need."

According to the DecisionBase 2013 report entitled On What Attributes Will Neurologists and Payers Differentiate Novel Therapies for Secondary-Pro
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. According to Surveyed Oncologists in the EU5, Zytiga Has Heavily Penetrated Second-Line Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC) and is Displacing Jevtana to Later-Line mCRPC
2. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
3. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
4. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
5. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
6. Mylan Launches Generic Lipitor® in Five European Countries
7. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
8. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
9. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
10. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
11. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... May 28, 2015 Compassion & Choices today is ... a bill that would authorize the option of medical aid ... The legislation, ... would allow mentally competent adults with six months or less ... take to painlessly and peacefully end an unbearable dying process. ...
(Date:5/28/2015)... and CAMBRIDGE, Mass., May 28, 2015  Shareholder ... investigating whether certain officers and directors of ... to shareholders.  Eleven Biotherapeutics is a clinical-stage biopharmaceutical ... of protein therapeutics to treat eye diseases, primarily ...   View this press release on ...
(Date:5/28/2015)... ALEXANDRIA, Va. , May 28, 2015 ... Hoey , RPh, MBA issued the following statement in ... the AARP Public Policy Institute documenting that a number ... "This new report tracks with concerns previously expressed ... Congress to support patient access to essential medications. Moreover, ...
Breaking Medicine Technology:California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2
... Reportlinker.com announces that a new market research ... Global Intraocular Lenses Industry ... the worldwide markets for Intraocular Lenses in US$ ... Lenses, and Foldable Intraocular Lenses. The report provides ...
... New Mexico Software, Inc. (OTC Bulletin ... and solutions that enable improved and faster communication within the healthcare ... diagnostic imaging services for the Heart Institute of the Caribbean ... Jamaica. HIC is now sending nuclear and other exams ...
Cached Medicine Technology:Reportlinker Adds Global Intraocular Lenses Industry 2New Mexico Software Launches Company's First International Telemedicine Service 2New Mexico Software Launches Company's First International Telemedicine Service 3
(Date:5/28/2015)... 28, 2015 Altima Technologies, Inc., ... Library for documenting and diagramming data center assets ... the following product lines: , Manufacturer / ... Chatsworth Products N-Series TeraFrame Cabinet, Middle Atlantic Products ... Fore Systems ForeRunner, Marantz America MM Series, Extron ...
(Date:5/28/2015)... The CEO and Founder of Alliance Hospice, ... series which provides analysis on the benefits of fostering ... Dalglish” profile on Blogger.com, this instructive new series was ... , “Throughout my business career, I’ve witnessed the ... overall success of businesses,” stated R. Bruce Dalglish, CEO ...
(Date:5/28/2015)... 28, 2015 Senior Housing Assistance Group ... Piniella, who managed the Seattle Mariners team that won ... appear in television and digital advertising for SHAG to ... communities, including several new communities slated to open in ... Lynnwood, Mountlake Terrace, Tukwila, and University Place. , Filming ...
(Date:5/28/2015)... 28, 2015 More than 300 locations ... raise money to help the Muscular Dystrophy Association save ... and related life-threatening diseases that limit muscle strength and ... program. , From June 1 to June 30, sweetFrog ... the opportunity to help send local children affected by ...
(Date:5/28/2015)... 28, 2015 Baptist Medical Center Jacksonville ... suffering from acute stroke or other neurological conditions. , ... of a few in the country and the first ... needs such as brain aneurysms. , “Baptist Health ... of patients who are impacted by stroke,” said Nicole ...
Breaking Medicine News(10 mins):Health News:NetZoom™ Visio® Stencil Library Updates for EMC, Cisco, and Chatsworth Products 2Health News:R. Bruce Dalglish, CEO of Alliance Hospice, Introduces New Blog Series On Positive Corporate Culture 2Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3
... Dana-Farber/Children,s Hospital Cancer Center (DF/CHCC) have found that ... for germ-cell ovarian tumors might safely be spared chemotherapy ... the follow-up treatment is needed., In contrast to the ... removal of these rare tumors, researchers said the study ...
... HealthDay Reporter , TUESDAY, Oct. 19 (HealthDay News) -- ... who decided to stop taking the cancer drug Gleevec (imatinib) ... The study, published online Oct. 19 in The Lancet ... the drug might go beyond long-term cancer control and offer ...
... has chosen Springer to publish its scientific research in ... d,urgence . Bruno Riou, Professor on the Pierre and ... is editor-in-chief of this official society journal. ... is targeted at the community of French emergency ...
... (HealthDay News) -- A new study confirms what ... alcohol slows reaction time and increases errors during decision-making. ... brain regions involved in error processing more than others. ... alcohol (control group) or different doses of alcohol in ...
... each year because they can,t afford a pacemaker. Meanwhile heart ... donate theirs after death to someone in need. In ... University of Michigan Cardiovascular Center examine the legality and logistics ... cremation, for sterilization and reuse across the globe. Small ...
... Goodwin HealthDay Reporter , TUESDAY, Oct. 19 ... if operating room staff borrowed team-building procedures used by ... program that trained operating room workers to talk about ... review what went right or wrong after surgeries significantly ...
Cached Medicine News:Health News:Girls with ovarian germ-cell tumors can safely skip chemotherapy unless disease recurs 2Health News:Some With Once-Deadly Leukemia Can Take a Break From Gleevec 2Health News:Some With Once-Deadly Leukemia Can Take a Break From Gleevec 3Health News:Recycling pacemakers may alleviate burden of heart disease across the globe 2Health News:Recycling pacemakers may alleviate burden of heart disease across the globe 3Health News:Lessons From Flight Crews Can Help Surgical Teams Work Better 2Health News:Lessons From Flight Crews Can Help Surgical Teams Work Better 3
Electric high speed system....
Designed to give maximum drying area while taking up minimal bench space....
Used to remove wrinkles from sections and for reorientating embedded tissue....
Compact instrument that quickly dries racks of slides using warm air....
Medicine Products: